Naunyn-Schmiedeberg's archives of pharmacology
The safety of rituximab in pediatric nephrotic syndrome patients: a pharmacovigilance study of the FAERS database.
Yanfeng Si, Fang Sun, Xu Wang, Xing Zhang, Rufeng Lin, Jiahua Ju, Yanqun Sun
Published: 202610.1007/s00210-026-05003-7
Abstract
This study aims to systematically evaluate the safety of rituximab (RTX) in pediatric nephrotic syndrome (NS) using real-world data from the US Food and Drug Administration Adverse Event Reporting System (FAERS). We analyzed FAERS data from Q1 2013 t…
Preview only. Read the full abstract at the source